S&P 500
(0.25%) 5 321.41 points
Dow Jones
(0.17%) 39 873 points
Nasdaq
(0.22%) 16 833 points
Oil
(-0.25%) $79.06
Gas
(-0.26%) $2.66
Gold
(-0.02%) $2 425.30
Silver
(0.63%) $32.28
Platinum
(0.09%) $1 061.90
USD/EUR
(0.04%) $0.921
USD/NOK
(-0.27%) $10.67
USD/GBP
(-0.04%) $0.787
USD/RUB
(-0.20%) $90.49

リアルタイムの更新: Ocugen Inc [OCGN]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
BUY
100.00%
return 9.47%
SELL
100.00%
return -10.94%
最終更新日時22 5月 2024 @ 05:00

-3.65% $ 1.850

買う 139829 min ago

@ $0.657

発行日: 15 2月 2024 @ 05:30


リターン: 181.80%


前回のシグナル: 2月 14 - 23:30


前回のシグナル: 売る


リターン: 6.16 %

Live Chart Being Loaded With Signals

Commentary (22 5月 2024 @ 05:00):
Profile picture for Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD...

Stats
本日の出来高 6.63M
平均出来高 9.47M
時価総額 476.06M
EPS $0 ( 2024-05-14 )
次の収益日 ( $-0.0600 ) 2024-08-19
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -8.04
ATR14 $0.00700 (0.38%)
Insider Trading
Date Person Action Amount type
2024-04-16 Qamar Huma Buy 308 465 Option (Right to Buy)
2024-03-18 Qamar Huma Sell 0 Common Stock
2023-09-15 Breininger Michael Buy 0
2024-01-03 Musunuri Shankar Sell 180 204 Common Stock
2024-01-03 Upadhyay Arun Sell 41 633 Common Stock
INSIDER POWER
65.74
Last 96 transactions
Buy: 10 862 012 | Sell: 2 992 475

ボリューム 相関

長: -0.17 (neutral)
短: -0.07 (neutral)
Signal:(55.66) Neutral

Ocugen Inc 相関

10 最も正の相関
QNST0.939
PVAL0.937
LFMDP0.935
RNA0.935
GRID0.933
DWLD0.932
AVO0.93
SG0.928
QFIN0.927
SHLD0.926
10 最も負の相関
UONEK-0.918
RMGC-0.904
PRTS-0.902
TTEC-0.902
ACAD-0.9
UONE-0.897
AGRX-0.895
EEIQ-0.895
NLSP-0.893
QNRX-0.892

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

Ocugen Inc 相関 - 通貨/商品

The country flag 0.00
( neutral )
The country flag -0.37
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.14
( neutral )
The country flag 0.59
( weak )

Ocugen Inc 財務諸表

Annual 2023
収益: $6.04M
総利益: $5.33M (88.34 %)
EPS: $-0.260
FY 2023
収益: $6.04M
総利益: $5.33M (88.34 %)
EPS: $-0.260
FY 2022
収益: $0
総利益: $-1.07M (0.00 %)
EPS: $-0.360
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $-0.300

Financial Reports:

No articles found.

Ocugen Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Ocugen Inc

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。